Julien is a PhD candidate in the Biological and Biomedical program at Harvard University. He is conducting his graduate work in the laboratory of Dr. Andrew Aguirre at Dana-Farber Cancer Institute and the Broad Institute. His research aims to understand response and resistance to RAS-targeted therapies in pancreatic cancer through large scale variant screens, single-cell RNAseq and genetically engineered models